Skip to content

Clinical trials

Phase 3 Coronary Artery Disease trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 3 Country / region: Spain Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20053
20061
20081
20091
20101
20111
20122
20133
20141
20181
20221
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting4
Unknown status3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Novartis Pharmaceuticals3
Boston Scientific Corporation2
Abbott Medical Devices1
Alvimedica1
CSL Behring1
Cordis US Corp.1
Daiichi Sankyo1
ECRI bv1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease22
Cardiovascular Diseases3
Myocardial Infarction3
Stroke3
Acute Coronary Syndrome2
Atherosclerosis2
Coronary Disease2
Coronary Stenosis2
Diabetes Mellitus2
Diabetes Mellitus, Type 22

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.